跳至主要内容
临床试验/TCTR20180222004
TCTR20180222004已完成4 期

Safety and hypoglycemic Efficacy of Bitter melon (Momordica charantin L.) capsules in pre - diabetes patients

ARDA0 个研究点目标入组 220 人开始时间: 2018年2月22日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
220

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 Years 至 60 Years(—)
性别
All

入选标准

  • 1 Fasting plasma glucose 100-125mg /dl or glycated hemoglobin (HbA1c) 5.7-6.4%
  • 2 Age 30-60 years old

排除标准

  • 1 Serum creatinine higher than 1.8 mg/dL
  • 2 Serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin or alkaline phosphatase higher than 2.5 times of the upper normal
  • 3 Hemogloblin lower than 10 g/dL
  • 4 Heart disease (Angina, heart failure with left ventricular hypertrophy (LVH))
  • 5 Pregnant and lactating women
  • 6 Patients was present sulfonylureas, metformin, thiazolidinediones, glitinides, alphaglucosidase
  • inhibitors or insulin use prior to study enrollment participation in another clinical trial within 30 days of screening

研究者

发起方
ARDA

相似试验